# Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care

> **NCT02084719** · NA · TERMINATED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 67 (actual)

## Conditions studied

- Active or Ex-injection Drug Users
- Indication of Hepatitis C Screening

## Interventions

- **DEVICE:** Oraquick HCV Rapid Antibody Test
- **DEVICE:** Standard algorithm

## Key facts

- **NCT ID:** NCT02084719
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 67 (ACTUAL)
- **Why stopped:** Slow recruitement
- **Last updated:** 2017-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02084719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02084719, "Comparison of OraQuick HCV Rapid Antibody Test and Standard Serologic Screening for Hepatitis C: Validity, Acceptability and Impact on Linkage to Care". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02084719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*